Inventor · disambiguated record
Todd Carter
Also filed as: CARTER TODD · CARTER TODD A
8 granted patents·35 pending applications·156 citations·filing 2001–2025
87Inventor score
Top patents by PatentIndex Score
43 records- 0194US7998971B2Combinations containing a 4-acylaminopyridine derivativeBRAINCELLS INC·Filed 2007·Granted Aug 16, 2011·77 cites·5 claims
- 0291US7985756B2Modulation of neurogenesis by PDE inhibitionBRAINCELLS INC·Filed 2006·Granted Jul 26, 2011·35 cites·2 claims
- 0390US7858611B2Neurogenesis by modulating angiotensinBRAINCELLS INC·Filed 2007·Granted Dec 28, 2010·10 cites·2 claims
- 0487US11512327B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2018·Granted Nov 29, 2022·3 cites·24 claims
- 0587US7678808B25 HT receptor mediated neurogenesisBRAINCELLS INC·Filed 2007·Granted Mar 16, 2010·14 cites·3 claims
- 0685US7678363B2Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIsBRAINCELLS INC·Filed 2006·Granted Mar 16, 2010·17 cites·2 claims
- 0776US12305189B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·6 claims
- 0866US12291565B2Tau binding compoundsVOYAGER THERAPEUTICS INC·Filed 2024·Granted May 6, 2025·0 cites·28 claims
- 0963US2025243263A1Tau binding compoundsVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1060US2010009983A15 ht receptor mediated neurogenesisBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 1159US2010216734A1Modulation of neurogenesis by nootropic agentsBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 1259US2009197823A1Aliskiren modulation of neurogenesisBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 1357US2009325949A15 ht receptor mediated neurogenesisBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 1456US2008188457A1Modulation of Neurogenesis with Biguanides and GSK3-beta AgentsBRAINCELLS INC·Filed 2008·Application pending·0 cites
- 1556US2008171750A1Modulation Of Neurogenesis With Use of ModafinilBRAINCELLS INC·Filed 2008·Application pending·0 cites
- 1656US2008167363A1Modulation of Neurogenesis By Melatoninergic AgentsBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 1755US2023192830A1Tau binding compoundsVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1855US2008103105A1HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESISBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 1955US2008103165A1Ppar mediated modulation of neurogenesisBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 2055US2025282854A1Tau binding compoundsVOYAGER THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2153US2024059766A1Tau binding compoundsVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2253US2023075314A1VECTORIZED ANTIBODIES (vAb) AND USES THEREOFVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2352US2007244143A1Modulation of neurogenesis by nootropic agentsBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 2451US2011092464A1Neurogenesis by modulating angiotensinBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 2549US2021371470A1Compositions and methods for delivery of aavVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2649US2021230632A1Compositions and methods for delivery of aavVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2749US2024000971A1Compositions and methods for the treatment of tauopathyVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2848US2009239834A1Mcc-257 modulation of neurogenesisBRAINCELLS INC·Filed 2009·Application pending·0 cites
- 2947US2006234931A1Treatment of diseases with kinase inhibitorsBIGGS WILLIAM H III·Filed 2004·Application pending·0 cites
- 3047US2022275367A1Compositions and methods for treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3144US2008108574A1Melanocortin receptor mediated modulation of neurogenesisBRAINCELLS INC·Filed 2007·Application pending·0 cites
- 3243US2022339270A1Compositions and methods for the treatment of tauopathyVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3343US2021355454A1Systems and methods for producing gene therapy formulationsVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3442US2007015138A1Methods for identifying agents and conditions that modulate neurogenesisBRAINCELLS INC·Filed 2006·Application pending·0 cites
- 3541US2007112017A1Gaba receptor mediated modulation of neurogenesisBRAINCELLS INC·Filed 2006·Application pending·0 cites
- 3640US2007078083A1MODULATION OF NEUORGENESIS BY HDac INHIBITIONBRAINCELLS INC·Filed 2006·Application pending·0 cites
- 3740US2010184806A1Modulation of neurogenesis by ppar agentsBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 3839US2002133837A1Transgenic animals at a nuclear hormone receptor locusFiled 2001·Application pending·0 cites
- 3937US2010120842A1Neurogenesis by muscarinic receptor modulationBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 4036US2011319386A1Neurogenesis by muscarinic receptor modulationBARLOW CARROLEE·Filed 2011·Application pending·0 cites
- 4135US2011269717A1Neurogenesis by modulating angiotensinBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 4233US2011046090A1Modulation of neurogenesis with gaba agents and gaba analogsBRAINCELLS INC·Filed 2010·Application pending·0 cites
- 4332US2010216805A1Modulation of neurogenesis using d-cycloserine combinationsBRAINCELLS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Todd Carter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →